MeSH term
Frequency | Condition_Probility | Adult | 20 | 0.0 |
Female | 32 | 0.0 |
Humans | 46 | 0.0 |
Laterality/*physiology | 2 | 6.0 |
Male | 28 | 0.0 |
Motor Cortex/*physiology | 2 | 10.0 |
Adolescent | 11 | 0.0 |
English Abstract | 3 | 0.0 |
*Theta Rhythm | 2 | 40.0 |
Animals | 8 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 21 | 0.0 |
Child | 11 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Electroencephalography | 2 | 0.0 |
Statistics, Nonparametric | 2 | 0.0 |
*Electroencephalography | 12 | 11.0 |
Fourier Analysis | 2 | 3.0 |
Middle Aged | 9 | 0.0 |
Factor VII/*genetics | 7 | 70.0 |
Factor VII Deficiency/*genetics | 5 | 50.0 |
Amino Acid Substitution | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
Genotype | 5 | 0.0 |
In Vitro | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Phenotype | 5 | 0.0 |
Point Mutation | 3 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Protein Conformation | 3 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Time Factors | 2 | 0.0 |
Predictive Value of Tests | 2 | 0.0 |
Factor VII Deficiency/blood/*genetics | 2 | 100.0 |
Heterozygote | 3 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Transfection | 3 | 0.0 |
Aged | 4 | 0.0 |
Angiotensin II Type 1 Receptor Blockers/*therapeutic use | 2 | 25.0 |
Benzimidazoles/*therapeutic use | 2 | 16.0 |
Double-Blind Method | 2 | 0.0 |
Hypertension/*prevention & control | 2 | 20.0 |
Tetrazoles/*therapeutic use | 2 | 13.0 |
Regression Analysis | 3 | 0.0 |
Comparative Study | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
Electrodes | 2 | 4.0 |
Molecular Sequence Data | 3 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Cerebral Cortex/physiopathology | 2 | 8.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Pedigree | 3 | 0.0 |
Sex Factors | 2 | 0.0 |
Mice | 2 | 0.0 |
Electrophoresis, Starch Gel | 2 | 1.0 |
*Hemoglobins, Abnormal | 2 | 11.0 |
Infant, Newborn | 2 | 0.0 |
Amino Acids/analysis | 2 | 0.0 |
